Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis. Williams CL, Billings J, McGowan H, McDevitt R, et al. Pediatr Pulmonol 2025;60:e71038.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Williams CL, Billings J, McGowan H, McDevitt R, et al. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis. Pediatr Pulmonol 2025;60:e71038.
PMID: 40067072